People

Search Language

中文(台灣) / Traditional Chinese | Use language selector above (below, on mobile) to search additional languages
  • Selected filters
  • x(Technology Companies Group)

342 items matching filters

448119

Practice:

  • Life Sciences & HealthTech
  • Technology Transactions
  • Technology Companies Group
  • Private Equity
  • Mergers & Acquisitions
  • Strategic Advisory & Government Enforcement (SAGE)

David Sharrow Partner

Boston

David brings a wealth of expertise, focusing on diverse cutting-edge technologies, including life sciences (biotechnology, pharmaceuticals, medical devices, digital health, genomic technology), fintech, artificial intelligence, information technology (hardware, software, SaaS, and database solutions), edtech, renewable energy, sustainable technologies, AR/VR and cybersecurity.

He advises clients on corporate partnerships, strategic alliances and licensing agreements with leading U.S. and global entities, as well as major research universities and institutes. His experience includes navigating the IP and technology aspects of venture capital financings, public offerings and some of the largest M&A transactions involving venture-backed companies.

David has lectured at major institutions, including Tulane, Yale, Princeton, NYU, Columbia, Cornell and Fordham.

Kyle Amendt Shimomura Associate

San Francisco

Kyle advises companies throughout their lifecycle, including formation, corporate and securities law, venture capital financings and corporate governance matters. In addition to advising companies, Kyle represents venture firms and other investors in connection with their investments in private companies.

Before practicing law, Kyle was a product manager in a leading medical device company. He also worked on multiple units of a nationally recognized children's hospital and sat on the Hospital Ethics Committee.

Practice:

  • Technology Companies Group
  • Private Equity
  • Mergers & Acquisitions

Damien Simonot Partner

Munich

He has many years of experience advising private equity investors, established companies and family offices as well as startups and scale-ups. He counsels clients on complex and often cross-border transactions, restructurings, joint ventures and buy-outs and other partnerships and investments in the tech sector and beyond.

Before joining Orrick, Damien worked for an international law firm in Munich and Frankfurt for more than eight years.

Practice:

  • Cyber, Privacy & Data Innovation
  • Technology Transactions
  • Strategic Advisory & Government Enforcement (SAGE)
  • Trademark, Copyright & Media
  • Intellectual Property

Alex Sobolev Partner

London

Alex’s multidisciplinary practice and transatlantic experience enable him to provide strategic commercial advice for technology led companies, including coordinating and implementing data and consumer risk mitigation projects, providing outsourcing advice and developing key legal risk mitigation strategies in relation to products where the pace of innovation nearly always outpaces the law.

He has advised companies at all stages of the corporate lifecycle, from software development and product launch, through technology licensing, sale and purchase, to mergers and acquisitions of data and tech-heavy businesses. He has assisted organisations with the design, development and implementation of global data protection and compliance policies, as well the management of risk and security associated with data retention, processing and transfer.

465979

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group
  • Life Sciences & HealthTech

Mark Solakian Partner

Boston

With more than three decades of experience advising both private and public companies—and having served as a senior in-house executive across multiple pioneering biotech and life sciences companies—Mark brings a uniquely business minded perspective to his counsel and delivers a rare blend of legal acumen and executive experience that positions him as a trusted strategic partner to entrepreneurs, companies and investors.

Mark is a veteran of hundreds of successful venture capital financings, technology and licensing transactions, strategic alliances, corporate governance matters, mergers and acquisitions, and public and private equity and debt offerings on behalf of companies in every health and biotech related vertical.

Before joining Orrick, Mark was a partner and co-founder of the Wilson Sonsini Boston office. He previously held senior executive roles at Affymetrix (AFFX), Helicos Biosciences (HLCS) and Joule Global Holdings, where he oversaw legal strategy, led public offerings and financings, negotiated strategic partnerships and licensing transactions, and managed critical business functions including HR, finance, and government affairs.

Mark and his wife, Christine, have been married for more than 25 years and have two adult children.